Call for proposals 2019 - Future Disruptive Defence Technologies PADR-FDDT-2019 Closed!
Objectives
The development of new defence products and services very often relies on incremental improvements of existing ones leading to a higher performance or more efficient operation of established capabilities. However, technologies are emerging that could – when used in a military context – radically change the balance of military power between opponents. Such disruptive technologies for defence then lead to game-changing shifts in military paradigms. Exploring innovative technologies for defence use is thus essential to alter or maintain technological dominance.
Actions
This call covers the following topics:
- PADR-FDDT-OPEN-03-2019: Challenging the future
- PADR-FDDT-EMERGING-03-2019: Emerging Game-changers
European community funding
The Community provisional funding available for the call for proposals is:
- 11,46 Million EUR (Global Budget)
All the important deadlines
- 03 September 2019 - more than one year ago (Deadline for the presentation of proposals)
- 28 September 2019 - more than one year ago (Deadline for the presentation of proposals)
- 30 June 2020 - 8 months ago (Deadline for the presentation of proposals)
Further information about the call
Official webpage of the call
Useful documents
Organisations eligible to participate
Opened to the following bodies or institutes with legal status established in the covered areas:
- Any legal organisation
Covered areas
Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:
- European Union (EU)
Directorate-Generale responsible
Directorate-General for Research
Related calls for proposals
- Call for proposals 2020 - Innovation Fund Small Scale Projects
- Horizon Prize 2020 - Unique Train
- Prize 2017 - Zero power water infrastructure monitoring
- Horizon Prize - Cleanest engine of the future
- Call for proposals 2020 - Pilot project - Develop Artificial Intelligence for diagnosis and treatment of paediatric cancer